Tirzepatide peptide overview Tirzepatide is a novel, once-weekly, injectable peptide medication that is being developed as a treatment for type 2 diabetes and obesity. It works by targeting multiple receptors in the body, including the glucagon-like peptide 1 (GLP-1) and the glucose-dependent insulinotropic peptide (GIP) receptors. Studies have shown that tirzepatide has a stronger glucose-lowering effect and greater weight loss benefit …